Insider Cluster (2 insiders) ·Filed Jul 2, 2026

MAZE

Maze Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $1.1M total
Actionable Insight • Neutral

The selling is too small to warrant a bearish read-through. Monitor for any upcoming clinical catalysts or earnings that could explain the CEO's sales; otherwise, treat as routine portfolio diversification.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+20d ⚠ clustered
MAZE ▼ -11.61% at T+20d
NEUTRAL call ✗ call lost -11.61% · α vs SPY -11.20% · entry $31.26 → $27.63
Next anchor: T+1d due 3mo ago
Entry anchored
Jul 1, 03:59 PM ET
via exchange tick
T+1d
—
call — · α —
—
due 3mo ago
T+5d
+3.71%
call +3.71% · α +2.78%
$32.42
settled 3mo ago
T+20d
-11.61%
call -11.61% · α -11.20%
$27.63
settled 2mo ago
T+60d
—
call — · α —
—
due 7d ago

Price Chart

Loading chart...

Executive Summary

CEO Jason Coloma sold ~$1.03M and CSBO Atul Dandekar sold $210K in open-market transactions over a 7-day window, totaling $1.12M. At 0.07% of MAZE's $1.6B market cap, the cluster is trivial in size and does not signal material insider concern.

Key Financial Metrics

Direction
selling
Total Value
$1.1M
Insiders
2

Key Facts

  • CEO Jason Coloma sold 34,501 shares for ~$1.03M on July 1, 2026
  • CSBO Atul Dandekar sold 7,500 shares for $210K on June 29 after exercising options
  • Total insider selling of $1.12M represents 0.07% of market cap
  • Both insiders are C-suite, but the dollar amount is immaterial relative to company size

Financial Impact

Insider selling of $1.12M is trivial relative to $1.6B market cap

dilution

Risk Factors

  • CEO selling could be perceived negatively by momentum traders despite small size
  • Further insider sales above 0.5% of market cap would be more concerning

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MAZE-1783061815504
19 reports for MAZE
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+5▲ +5.16%Jun 3, 2026
Filters
Rows
Reports for MAZE — sortable, filterable
TypeNow
Sep 4, 2026
27d ago
Insider Cluster
NEUTRAL ★ 2/10
$26.37 $24.23▼ −8.12%▼ −7.00%$26.69 (+1.20%)
Sep 4, 2026
27d ago
Insider Cluster
NEUTRAL ★ 3/10
$26.37 $24.23▼ −8.12%▼ −7.00%$26.69 (+1.20%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$25.87 $24.60▼ −4.91%▼ −3.76%$26.69 (+3.16%)
Sep 2, 2026
29d ago
144
NEUTRAL ★ 2/10
$25.87 $24.60▼ −4.91%▼ −3.76%$26.69 (+3.16%)
Sep 1, 2026
4w ago
144
NEUTRAL ★ 3/10
$26.72 $24.82▼ −7.11%▼ −6.15%$26.69 (−0.12%)
Aug 17, 2026
6w ago
3
NEUTRAL ★ 1/10
$29.13 $30.42▲ +4.43%▲ +4.63%$26.69 (−8.38%)
Aug 11, 2026
7w ago
Press Release
NEUTRAL ★ 4/10
$27.53 $29.75▲ +8.06%▲ +8.51%$26.69 (−3.06%)
Aug 7, 2026
8w ago
Institutional Cluster
BULLISH ★ 5/10
$28.65 $27.18▼ −5.13%▼ −5.53%$26.69 (−6.85%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$27.81 $27.53▼ −1.01%▼ −1.36%$26.69 (−4.04%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$31.26 $32.42▲ +3.71%▲ +2.78%$26.69 (−14.63%)
Showing 10 of 19

US Market Status

Market Open — Closes in 3h 57m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 3, 2026